EBANGA

This brand name is authorized in United States.

Active ingredients

The drug EBANGA contains one active pharmaceutical ingredient (API):

1	Ansuvimab UNII TG8IQ19NG2 - ANSUVIMAB
	Ansuvimab is a recombinant human monoclonal antibody with antiviral activity against Zaire ebolavirus.
	Read more about Ansuvimab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EBANGA Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BD04		J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BD Antiviral monoclonal antibodies
Discover more medicines within J06BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	80673-001, 80673-777